Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
25841 | 270 | 43.7 | 80% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
4 | 4 | ENVIRONMENTAL SCIENCES//GEOSCIENCES, MULTIDISCIPLINARY//METEOROLOGY & ATMOSPHERIC SCIENCES | 1766162 |
184 | 3 | METALLOTHIONEIN//WILSONS DISEASE//CADMIUM | 56156 |
1113 | 2 | WILSONS DISEASE//METALLOTHIONEIN//ATP7B | 9713 |
25841 | 1 | TETRATHIOMOLYBDATE//CLIOQUINOL//UNITA RIC CATANIA | 270 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TETRATHIOMOLYBDATE | authKW | 1017801 | 11% | 30% | 30 |
2 | CLIOQUINOL | authKW | 890798 | 11% | 25% | 31 |
3 | UNITA RIC CATANIA | address | 628289 | 4% | 56% | 10 |
4 | ANTICOPPER THERAPY | authKW | 339281 | 1% | 100% | 3 |
5 | IBDML UMR CNRS 6216 | address | 226187 | 1% | 100% | 2 |
6 | QUINOLIN 8 OL HALOGEN DERIVATIVES | authKW | 226187 | 1% | 100% | 2 |
7 | ATN 224 | authKW | 203566 | 1% | 60% | 3 |
8 | IBDML UMR 6216 | address | 201051 | 1% | 44% | 4 |
9 | COPPER CHELATION | authKW | 195609 | 3% | 22% | 8 |
10 | TRIENTINE | authKW | 185577 | 3% | 21% | 8 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 579 | 25% | 0% | 68 |
2 | Chemistry, Medicinal | 474 | 13% | 0% | 35 |
3 | Chemistry, Inorganic & Nuclear | 123 | 9% | 0% | 23 |
4 | Biochemistry & Molecular Biology | 98 | 20% | 0% | 53 |
5 | Crystallography | 54 | 4% | 0% | 12 |
6 | Pharmacology & Pharmacy | 54 | 11% | 0% | 29 |
7 | Medicine, Research & Experimental | 52 | 6% | 0% | 17 |
8 | Cell Biology | 25 | 7% | 0% | 19 |
9 | Medical Laboratory Technology | 25 | 2% | 0% | 5 |
10 | Chemistry, Multidisciplinary | 13 | 8% | 0% | 21 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UNITA RIC CATANIA | 628289 | 4% | 56% | 10 |
2 | IBDML UMR CNRS 6216 | 226187 | 1% | 100% | 2 |
3 | IBDML UMR 6216 | 201051 | 1% | 44% | 4 |
4 | TAUBMAN HLTH 1904 | 150790 | 1% | 67% | 2 |
5 | BMSS | 113094 | 0% | 100% | 1 |
6 | CONSORZIO INTERUNIV RIC CHIM METALLI SISTEMI BIOL | 113094 | 0% | 100% | 1 |
7 | DAVIS HEART LUNG 512 MOL MED | 113094 | 0% | 100% | 1 |
8 | IBDMLUMR 6216CNRS | 113094 | 0% | 100% | 1 |
9 | INSERM 631 | 113094 | 0% | 100% | 1 |
10 | INSERMJEAN PIERRE AUBERT | 113094 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MEDCHEMCOMM | 3008 | 2% | 0% | 6 |
2 | TRANSLATIONAL RESEARCH | 1887 | 1% | 0% | 4 |
3 | JOURNAL OF TRACE ELEMENTS IN EXPERIMENTAL MEDICINE | 1572 | 1% | 1% | 2 |
4 | JOURNAL OF INORGANIC BIOCHEMISTRY | 1276 | 3% | 0% | 8 |
5 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 1202 | 4% | 0% | 10 |
6 | CURRENT CANCER DRUG TARGETS | 1065 | 1% | 0% | 3 |
7 | EXPERIMENTAL BIOLOGY AND MEDICINE | 683 | 1% | 0% | 4 |
8 | EJHP PRACTICE | 566 | 0% | 1% | 1 |
9 | CHEMPLUSCHEM | 499 | 1% | 0% | 2 |
10 | POLYCYCLIC AROMATIC COMPOUNDS | 468 | 1% | 0% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TETRATHIOMOLYBDATE | 1017801 | 11% | 30% | 30 | Search TETRATHIOMOLYBDATE | Search TETRATHIOMOLYBDATE |
2 | CLIOQUINOL | 890798 | 11% | 25% | 31 | Search CLIOQUINOL | Search CLIOQUINOL |
3 | ANTICOPPER THERAPY | 339281 | 1% | 100% | 3 | Search ANTICOPPER+THERAPY | Search ANTICOPPER+THERAPY |
4 | QUINOLIN 8 OL HALOGEN DERIVATIVES | 226187 | 1% | 100% | 2 | Search QUINOLIN+8+OL+HALOGEN+DERIVATIVES | Search QUINOLIN+8+OL+HALOGEN+DERIVATIVES |
5 | ATN 224 | 203566 | 1% | 60% | 3 | Search ATN+224 | Search ATN+224 |
6 | COPPER CHELATION | 195609 | 3% | 22% | 8 | Search COPPER+CHELATION | Search COPPER+CHELATION |
7 | TRIENTINE | 185577 | 3% | 21% | 8 | Search TRIENTINE | Search TRIENTINE |
8 | 5 7 DIBROMO 8 QUINOLINOL | 113094 | 0% | 100% | 1 | Search 5+7+DIBROMO+8+QUINOLINOL | Search 5+7+DIBROMO+8+QUINOLINOL |
9 | 5 7 DICHLORO 8 QUINOLINOLINE | 113094 | 0% | 100% | 1 | Search 5+7+DICHLORO+8+QUINOLINOLINE | Search 5+7+DICHLORO+8+QUINOLINOLINE |
10 | 5 7 DIHALO 8 QUINOLINOL TINIV COMPLEX | 113094 | 0% | 100% | 1 | Search 5+7+DIHALO+8+QUINOLINOL+TINIV+COMPLEX | Search 5+7+DIHALO+8+QUINOLINOL+TINIV+COMPLEX |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BREWER, GJ , (2014) THE PROMISE OF COPPER LOWERING THERAPY WITH TETRATHIOMOLYBDATE IN THE CURE OF CANCER AND IN THE TREATMENT OF INFLAMMATORY DISEASE.JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY. VOL. 28. ISSUE 4. P. 372 -378 | 28 | 80% | 5 |
2 | OLIVERI, V , VECCHIO, G , (2016) 8-HYDROXYQUINOLINES IN MEDICINAL CHEMISTRY: A STRUCTURAL PERSPECTIVE.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. VOL. 120. ISSUE . P. 252 -274 | 44 | 28% | 4 |
3 | CROWE, A , JACKAMAN, C , BEDDOES, KM , RICCIARDO, B , NELSON, DJ , (2013) RAPID COPPER ACQUISITION BY DEVELOPING MURINE MESOTHELIOMA: DECREASING BIOAVAILABLE COPPER SLOWS TUMOR GROWTH, NORMALIZES VESSELS AND PROMOTES T CELL INFILTRATION.PLOS ONE. VOL. 8. ISSUE 8. P. - | 24 | 52% | 7 |
4 | MEDICI, V , STURNIOLO, GC , (2008) TETRATHIOMOLYBDATE, A COPPER CHELATOR FOR THE TREATMENT OF WILSON DISEASE, PULMONARY FIBROSIS AND OTHER INDICATIONS.IDRUGS. VOL. 11. ISSUE 8. P. 592 -606 | 26 | 50% | 10 |
5 | MCCUBBIN, MD , HOU, GQ , ABRAMS, GD , DICK, R , ZHANG, Z , BREWER, GJ , (2006) TETRATHIOMOLYBDATE IS EFFECTIVE IN A MOUSE MODEL OF ARTHRITIS.JOURNAL OF RHEUMATOLOGY. VOL. 33. ISSUE 12. P. 2501-2506 | 20 | 67% | 7 |
6 | ASKARI, F , INNIS, D , DICK, RB , HOU, GQ , MARRERO, J , GREENSON, J , BREWER, GJ , (2010) TREATMENT OF PRIMARY BILIARY CIRRHOSIS WITH TETRATHIOMOLYBDATE: RESULTS OF A DOUBLE-BLIND TRIAL.TRANSLATIONAL RESEARCH. VOL. 155. ISSUE 3. P. 123 -130 | 14 | 74% | 7 |
7 | BREWER, GJ , (2012) METALS IN THE CAUSATION AND TREATMENT OF WILSON'S DISEASE AND ALZHEIMER'S DISEASE, AND COPPER LOWERING THERAPY IN MEDICINE.INORGANICA CHIMICA ACTA. VOL. 393. ISSUE . P. 135-141 | 22 | 42% | 15 |
8 | BREWER, GJ , DICK, R , ZENG, CH , HOU, GQ , (2006) THE USE OF TETRATHIOMOLYBDATE IN TREATING FIBROTIC, INFLAMMATORY, AND AUTOIMMUNE DISEASES, INCLUDING THE NON-OBESE DIABETIC MOUSE MODEL.JOURNAL OF INORGANIC BIOCHEMISTRY. VOL. 100. ISSUE 5-6. P. 927-930 | 17 | 63% | 10 |
9 | HOU, GQ , DICK, R , ZENG, CH , BREWER, GJ , (2006) COMPARISON OF LOWERING COPPER LEVELS WITH TETRATHIOMOLYBDATE AND ZINC ON MOUSE TUMOR AND DOXORUBICIN MODELS.TRANSLATIONAL RESEARCH. VOL. 148. ISSUE 6. P. 309-314 | 14 | 67% | 5 |
10 | BREWER, GJ , (2009) THE USE OF COPPER-LOWERING THERAPY WITH TETRATHIOMOLYBDATE IN MEDICINE.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 18. ISSUE 1. P. 89-97 | 21 | 38% | 17 |
Classes with closest relation at Level 1 |